Gheorghiade, M., Gattis, W. A., Lukas, M. A., O’Connor, C. M., & Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure Investigators, . (2003). Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study. Am Heart J, 145(2 Suppl), S60–S61. https://doi.org/10.1067/mhj.2003.157

Gheorghiade, Mihai, Wendy A. Gattis, Mary Ann Lukas, Christopher M. O’Connor, and Christopher M. Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure Investigators. “Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.” Am Heart J 145, no. 2 Suppl (February 2003): S60–61. https://doi.org/10.1067/mhj.2003.157.

Gheorghiade M, Gattis WA, Lukas MA, O’Connor CM, Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure Investigators. Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study. Am Heart J. 2003 Feb;145(2 Suppl):S60–1.

Gheorghiade, Mihai, et al. “Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.” Am Heart J, vol. 145, no. 2 Suppl, Feb. 2003, pp. S60–61. Pubmed, doi:10.1067/mhj.2003.157.

Gheorghiade M, Gattis WA, Lukas MA, O’Connor CM, Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure Investigators. Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study. Am Heart J. 2003 Feb;145(2 Suppl):S60–S61.